ADALIMUMAB REDUCES ACUTE INFLAMMATORY LESIONS IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: MRI RESULTS OF A 52-WEEK, OPEN-LABEL TRIAL

H. Haibel, M. Rudwaleit , H. Brandt , Z. Grozdanovic , J. Braun , H. Kupper , J. Sieper Rheumatology, Radiology, University Hospital Charité Campus Benjamin Franklin, Berlin, Rheumatology, Centre of Rheumatology Ruhrgebiet, Herne, Immunology, Abbott Laboratories, Ludwigshafen, GermanyCitation: Ann Rheum Dis, volume 64, supplement III, year 2005, page 571Session: Spondylarthropathies including psoriatic arthritis